According to GuruFocus Insider Data, these are the largest CEO buys during the past week.
Odonate Therapeutics CEO bought 128,255 shares
Odonate Therapeutics Inc. (ODT, Financial) CEO and 10% Owner Kevin C. Tang bought 128,255 shares on Feb. 16 at a price of $22.47. The price of the stock has increased by 11.04% since.
Odonate Therapeutics is a pharmaceutical company which is engaged in the development of therapeutics which improves and extend the lives of patients with cancer. The company has a market cap of $681.92 million. Its shares traded at $24.95 as of Feb. 16.
Net loss for the three months ended Dec. 31, 2017, was $15.7 million compared to $1.9 million for the same period in 2016.
On Dec. 11, 2017, Odonate announced the closing of its initial public offering of 6.25 million shares of common stock at a public offering price of $24.00 per share.
W. R. Grace & Co. CEO bought 25,000 shares
W. R. Grace & Co. (GRA, Financial) Chairman and CEO Alfred E. Festa bought 25,000 shares on Feb. 12 at a price of $65.38. The price of the stock has increased by 3.17% since.
W. R. Grace & Co. is engaged in the production and sale of specialty chemicals and specialty materials. It operates through three segments, Catalysts Technologies, Materials Technologies and Construction Products. The company has a market cap of $4.57 billion. Its shares traded at $67.45 with a price-earnings (P/E) ratio of 421.56 as of Feb. 16.
Net income (loss) for the fourth quarter of 2017 was $123.1 million compared to $15.6 million for the prior-year period.
Senior Vice President and Chief Financial Officer Thomas E. Blaser bought 5,300 shares on Feb. 13 at a price of $65.32. The price of the stock has increased by 3.26% since.
Vice President of Government Relations and Environment, Health and Safety Keith N. Cole bought 1,000 shares on Feb. 14 at a price of $65.76. The price of the stock has increased by 2.57% since.
Gaming and Leisure Properties CEO bought 40,000 shares
Gaming and Leisure Properties Inc. (GLPI, Financial) Chairman, CEO, and President Peter M. Carlino bought 40,000 shares on Feb. 12 at a price of $33.33. The price of the stock has increased by 1.32% since.
Gaming and Leisure Properties is a self-managed Pennsylvania REIT. It is engaged in acquiring, financing and owning real estate property to be leased to gaming operators in triple-net lease arrangements. The company has a market cap of $7.18 billion. Its shares traded at $33.77 with a price-earnings (P/E) ratio of 18.87 as of Feb. 16.
Net income for the fourth quarter of 2017 was $93.3 million compared to $93.7 million for the prior-year period.
Chief Financial Officer, Senior Vice President and Treasurer William J. Clifford bought 85,000 shares on Feb. 13 at a price of $33. The price of the stock has increased by 2.33% since.
AT&T CEO-AT&T Communications LLC John Donovan bought 27,997 shares
AT&T Inc. (T, Financial) CEO-AT&T Communications LLC John Donovan bought 27,997 shares on Feb. 9 at a price of $35.68. The price of the stock has increased by 4.09% since.
AT&T is engaged in providing communications and digital entertainment services in the U.S. and the world. It provides fixed-line services, including voice, data and television services to consumers and small businesses. The company has a market cap of $228 billion. Its shares traded at $37.14 with a price-earnings (P/E) ratio of 7.80 as of Feb. 16.
Net income for the third quarter of 2017 was $3.12 billion compared to $3.42 billion for the year-ago period.
Director Richard W. Fisher bought 2,600 shares on Feb. 5 at a price of $38.10. The price of the stock has decreased by 2.52% since.
Senior Executive Vice President – AT&T/Time Warner Merger Integration Planning John T. Stankey sold 2,307 shares on Feb. 1 at a price of $39.21. The price of the stock has decreased by 5.28% since.
OPKO CEO bought 185,000 shares
OPKO Health Inc. (OPK, Financial) CEO, Chairman and 10% Owner Phillip Frost bought 185,000 shares on Feb. 9 at a price of $3.83.
OPKO is a diversified health care company. Its business includes diagnostics and provision of pharmaceutical products. The company has a market cap of $2.15 billion. Its shares traded at $3.85 as of Feb. 16.
Net loss for the three months ended Sept. 30, 2017, was $46.44 million compared to $14.98 million for the prior-year period.
Frost bought 50,000 shares on Feb. 5 at a price of $4.14; 60,000 shares on Feb. 6 at a price of $4.22; 78,000 shares on Feb. 7 at a price of $4.22; 20,000 shares on Feb. 8 at a price of $4.04; and 185,000 shares on Feb. 9 at a price of $3.83. The price of the stock has increased by 0.52% since.
For the complete list of stocks that were bought by their company CEOs, go to: CEO Buys.
Disclosure: I do not own stock in any of the companies mentioned in the article.
